Past and current cause-specific mortality in Eisenmenger syndrome

Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects

(2016) Gerhard-Paul Diller et al.   EUROPEAN HEART JOURNAL

Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary CentreCLINICAL PERSPECTIVE

(2015) Gerhard-Paul Diller et al.   CIRCULATION

Impaired Right, Left, or Biventricular Function and Resting Oxygen Saturation Are Associated With Mortality in Eisenmenger SyndromeCLINICAL PERSPECTIVE

(2015) Annette S. Jensen et al.   Circulation-Cardiovascular Imaging

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease

(2015) A S Jensen et al.   HEART

Anticoagulation in adults with congenital heart disease: The who, the when and the how?

(2014) A S Jensen et al.   HEART

The haematocrit – an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease

(2013) A.S. Jensen et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Echocardiographic Predictors of Outcome in Eisenmenger Syndrome

(2012) Pamela Moceri et al.   CIRCULATION

Increased mortality among patients taking digoxin--analysis from the AFFIRM study

(2012) M. G. Whitbeck et al.   EUROPEAN HEART JOURNAL

B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy

(2012) Gerhard-Paul Diller et al.   HEART

Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease

(2012) A.S. Jensen et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Acute and short-term hemodynamic effects of metoprolol in Eisenmenger syndrome: A preliminary observational study

(2011) Sivasubramanian Ramakrishnan et al.   AMERICAN HEART JOURNAL

Iron deficiency is associated with adverse outcome in Eisenmenger patients

(2011) A. Van De Bruaene et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension

(2009) Konstantinos Dimopoulos et al.   CIRCULATION

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study

(2007) Michael A. Gatzoulis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY